Endocyte

Endocyte was a biopharmaceutical company that focused on developing targeted therapies for cancer and inflammatory diseases using its proprietary small molecule drug conjugate technology. The company was acquired by Novartis in 2018 and its operations were integrated into the parent organization's pharmaceutical development efforts. UpGuard continuously monitors the security posture of Endocyte using open-source, commercial, and proprietary threat intelligence feeds. Our analysis is centered on objective, externally verifiable information.

Endocyte Security Rating

X
---
/ 950
Endocyte's security rating is based on the analysis of their external attack surface. The higher the rating, the better their security posture. Start a free trial to get a more in-depth risk assessment for Endocyte.

Company info

Endocyte
Company
Endocyte
Employees
Location
CEO
P. Ron Ellis
Last updated
Last updated
Industries
Last updated today

Endocyte Vendor Risk Report

This vendor risk report is based on UpGuard’s continuous monitoring of Endocyte's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Last updated today

Endocyte Data Breaches, Cybersecurity Incidents and News

Security incidents, news, and data leaks relating to Endocyte.

Security reports related to Endocyte

Compare Endocyte's security performance with other companies in their industry.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating